The High Risk Prescription of Hope The University of California, San Diego study on leucovorin prescriptions for children with autism reveals a disturbing trend: after President Trump and other officials touted its potential benefits, the prescription rate skyrocketed by 2,000%.
This surge was fueled by media attention and public statements from White House officials. Researchers emphasize that their study does not weigh in on leucovorin's effectiveness for autism.
However, they acknowledge that widespread promotion of this medication has put many families at risk.